BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23060293)

  • 21. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.
    Aluisio L; Lord B; Barbier AJ; Fraser IC; Wilson SJ; Boggs J; Dvorak LK; Letavic MA; Maryanoff BE; Carruthers NI; Bonaventure P; Lovenberg TW
    Eur J Pharmacol; 2008 Jun; 587(1-3):141-6. PubMed ID: 18499098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.
    Hoepping A; Johnson KM; George C; Flippen-Anderson J; Kozikowski AP
    J Med Chem; 2000 May; 43(10):2064-71. PubMed ID: 10821718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological characterization of (3R,4R)-4-(2-(benzhydryloxy)ethyl)-1-((R)-2-hydroxy-2-phenylethyl)-piperidin-3-ol and its stereoisomers for activity toward monoamine transporters.
    Kharkar PS; Batman AM; Zhen J; Beardsley PM; Reith ME; Dutta AK
    ChemMedChem; 2009 Jul; 4(7):1075-85. PubMed ID: 19449323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
    Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
    Zheng YY; Gao K; Weng ZJ; Li JQ
    Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.
    Zhang P; Terefenko EA; Bray J; Deecher D; Fensome A; Harrison J; Kim C; Koury E; Mark L; McComas CC; Mugford CA; Trybulski EJ; Vu AT; Whiteside GT; Mahaney PE
    J Med Chem; 2009 Sep; 52(18):5703-11. PubMed ID: 19722525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
    Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
    Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
    Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.
    Smith JA; Bourdet DL; Daniels OT; Ding YS; Gallezot JD; Henry S; Kim KH; Kshirsagar S; Martin WJ; Obedencio GP; Stangeland E; Tsuruda PR; Williams W; Carson RE; Patil ST
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
    Skolnick P; Popik P; Janowsky A; Beer B; Lippa AS
    Eur J Pharmacol; 2003 Feb; 461(2-3):99-104. PubMed ID: 12586204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity.
    Fang X; Guo L; Jia J; Jin GZ; Zhao B; Zheng YY; Li JQ; Zhang A; Zhen XC
    Acta Pharmacol Sin; 2013 Sep; 34(9):1149-55. PubMed ID: 23892272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAR studies of piperidine-based analogues of cocaine. 4. Effect of N-modification and ester replacement.
    Petukhov PA; Zhang J; Kozikowski AP; Wang CZ; Ye YP; Johnson KM; Tella SR
    J Med Chem; 2002 Jul; 45(15):3161-70. PubMed ID: 12109901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine.
    Janowsky A; Tosh DK; Eshleman AJ; Jacobson KA
    J Pharmacol Exp Ther; 2016 Apr; 357(1):24-35. PubMed ID: 26813929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further structure-activity relationship studies of piperidine-based monoamine transporter inhibitors: effects of piperidine ring stereochemistry on potency. Identification of norepinephrine transporter selective ligands and broad-spectrum transporter inhibitors.
    He R; Kurome T; Giberson KM; Johnson KM; Kozikowski AP
    J Med Chem; 2005 Dec; 48(25):7970-9. PubMed ID: 16335921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2019 Nov; 862():172632. PubMed ID: 31473161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
    Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.